J Cardiothorac Vasc Anesth. 2021 Jul 22:S1053-0770(21)00613-3. doi: 10.1053/j.jvca.2021.07.032. Online ahead of print.
ABSTRACT
In this review, recent key publications related to acute coronary syndrome (ACS) are summarized and placed into context of contemporary practice. Landmark trials examining vascular access in ST-elevation myocardial infarction, the management of multivessel disease, acute myocardial infarction and cardiac arrest are discussed. An update in pharmacology for ACS provides updates in major trials relating to P2Y12 inhibitor initiation, deescalation, and use in special populations. Additional updates in the use of lipid-lowering agents and adjunctive medications in ACS are reviewed. Finally, cardiac pathology related to coronavirus disease 2019 (COVID-19), as well as the impact of the COVID-19 global pandemic on the care of patients with ACS, is summarized.
PMID:34400062 | DOI:10.1053/j.jvca.2021.07.032